Aribio Co., Ltd.
Records under this name other than the patents Aribio Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 13 patents it holds.
Showing 1 to 5 of 5 · Back to Aribio Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,485,124 | Methods for Treating Alzheimer Disease and for Reducing Amyloid Beta Formation Formerly held In force · Low confidence | In force | Low confidence | |
| US 8,742,160 | Method for preparing tricyclic derivatives Lapsed on the fee record Ended Jun 3, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 3, 2026 | From the USPTO record |
| US 7,410,955 | Therapeutic use of agonist ligands specific to G2A receptor Term ended Term ended Mar 25, 2023 · From the USPTO record | Term ended | Term ended Mar 25, 2023 | From the USPTO record |
| US 6,753,430 | Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof Term ended Term ended Nov 20, 2021 · From the USPTO record | Term ended | Term ended Nov 20, 2021 | From the USPTO record |
| US 6,649,763 | Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof Term ended Term ended Nov 16, 2021 · From the USPTO record | Term ended | Term ended Nov 16, 2021 | From the USPTO record |